Triamcinolone Acetonide Injection shortage
Resolved 1 presentations · 1 manufacturers · first FDA posting 2021-09-27 · last update 2026-07-31
Manufacturers: Harrow Eye, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01) | Harrow Eye, LLC | Resolved | — | Posted 09/27/2021 Updated 07/31/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)